Scholar Rock Holding Corporation is a biopharmaceutical company that specializes in the discovery and development of innovative medicines to treat serious diseases. With a focus on targeting the TGFβ1 pathway, the company aims to develop breakthrough therapies for conditions such as cancer, fibrosis, and musculoskeletal disorders. Utilizing its proprietary platform, Scholar Rock seeks to deliver transformative treatments to improve patients’ lives.
